
INmune Bio Engages Quantum Computing Inc. to Expand Drug Indication Discovery for XPro
INmune Bio and Quantum Computing Inc. are collaborating to use quantum optimization and AI for drug discovery. QCi's Dirac-3S quantum machine will analyze clinical data to find new disease indications for INmune Bio's neuroinflammation drug, XPro. This partnership aims to identify rare and pediatric disease indications for accelerated FDA review.


















